Profiling phospholipid elution in reversed-phase LC-MS/MS bioanalytical methods in order to avoid matrix effects

Bioanalysis

Volumn 4, Issue 8, 2012, Pages 879-895

  Silvester, Steve ^a   Smith, Luke ^b  

^a ASTRAZENECA   (United Kingdom)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; GLYCEROPHOSPHORYLCHOLINE; METHANOL; PHOSPHOLIPID;

ARTICLE; CONTROLLED STUDY; ELUTION; HUMAN; NONHUMAN; ORGANIC CHEMISTRY; PH; PLASMA; PROTEIN DETERMINATION; PROTEIN PROCESSING; QUALITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY;

ACETONITRILES; ANIMALS; CHROMATOGRAPHY, REVERSE-PHASE; DOGS; GLYCERYLPHOSPHORYLCHOLINE; HUMANS; HYDROGEN-ION CONCENTRATION; METHANOL; RATS; TANDEM MASS SPECTROMETRY;

EID: 84860304694     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.33     Document Type: Article

References (19)

1. Trufelli H, Palma P, Famiglini G, Cappiello A. An overview of matrix effects in liquid chromatography-mass spectrometry. Mass Spectrom. Rev. 30, 491-509 (2011). nnReview of matrix effects covering their mechanistic causes, evaluation and avoidance.
2. Antignac JP, Wash F, Monteau HD, Brabander FA, Bizet BL. The ion suppression phenomenon in liquid chromatography-mass spectrometry and its consequences in the field of residue analysis. Anal. Chim. Acta. 529, 129-136 (2005).
3. Côté C, Bergeron A, Mess J-N, Furtado M, Garofolo F. Matrix effect elimination during LC-MS/MS bioanalytical method development. Bioanalysis. 1(7), 1243-1257 (2009). nnReview of matrix effects with special emphasis on bioanalytical applications.
4. Ahnoff M, Wurzer A, Lindmark B, Jussila R. Characterisation of serum albumin and lysoPCs as major contributors to plasma sample matrix effects on electrospray ionization efficiency. Proceedings of: The 51st ASMS Conference on Mass Spectrometry and Allied Topics. Montreal, Quebec, Canada, 8-12 June 2003. nnIdentified plasma phospholipids as a major cause of matrix effect.
5. Bennett PK, Van Horne KC. Identification of the major endogenous and persistent compounds in plasma, serum and tissue that cause matrix effects with electrospray LC/MS techniques. Presented at: American Association of Pharmaceutical Scientists Conference. Salt Lake City, Utah, 26-30 October 2003. nnIdentified plasma phospholipids as a major cause of matrix effect.
6. Little JL, Wempe MF, Buchanan CM. Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: Examining lipid matrix ionization effects in plasma. J. Chromatogr. B 833, 219-230 (2006). nnSimple in-source collision-induced dissociation method to monitor glycerophophocholines by LC-MS.
7. Xia Y-Q, Jemal M. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: Comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects. Rapid Commun. Mass Spectrom. 23, 2125-2138 (2009). nnCompares relative merits of three methods for monitoring plasma phospholipids and explores the effect of mobile phase.
8. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J. Chromatogr. B 852, 22-34 (2007). (Pubitemid 46830084)
9. Lahaie M, Mess J-N, Furtado M, Garofolo. Elimination of LC-MS/MS matrix effect due to phospholipids using specific solid-phase extraction conditions. Bioanalysis 2(6), 1011-1021 (2010). nIdentified poor elution of phospholipids with 100% acetonitrile in silica-based SPE workflows.
10. Kole PL, Venkatesh G, Kotecha J, Sheshala R. Recent advances in sample preparation techniques for effective bioanalytical methods. Biomed. Chromatogr. 25, 199-217 (2011).
11. Ye Z, Tsao H, Gao H, Brummel CL. Minimizing matrix effects while preserving throughput in LC-MS/MS bioanalysis. Bioanalysis 3(14), 1587-1601 (2011).
12. Neville D. In silico prediction of retention times as a strategy to avoid matrix effects in LC-MS/MS bioanalysis. Chromatography Today 3(2), 18-20 (2010). nUse of in silico techniques to predict phospholipid elution.
13. Jemal M, Ouyang Z, Xia Y-Q. Systematic LC-MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography. Biomed. Chromatogr. 24, 2-19 (2010).
14. Ramanathan R, Jemal M, Ramagiri S et al. It is time for a paradigm shift in drug discovery bioanalysis: From SRM to HRMS. J. Mass. Spectrom. 46, 595-601 (2011).
15. Bell DS, Jones AD. Solute attributes and molecular interactions contributing to 'U-shape' retention on a fluorinated high-performance liquid chromatography stationary phase. J. Chromatogr. A 1073, 99-109 (2005). (Pubitemid 40544481)
16. Hupp AM, McGuffin VL. Thermodynamic and kinetic characterization of a bridged-ethylene hybrid C18 stationary phase. J. Chromatogr. A 1217, 6241-6249 (2010).
17. Wu ST, Schoener D, Jemal M. Plasma phospholipids implicated in the matrix effect observed in liquid chromatography/tandem mass spectrometry bioanalysis: Evaluation of the use of colloidal silica in combination with divalent or trivalent cations for the selective removal of phospholipids from plasma. Rapid Commun. Mass Spectrom. 22, 2873-2881 (2008).
18. Tang C-H, Tsao P-N, Chen C-Y, Shiao M-S, Wang W-H, Lin C-Y. Glycerophosphocholine molecular species profiling in the biological tissue using UPLC/MS/MS. J. Chromatogr. B 879, 2095-2106 (2011).
19. Méndez A, Bosch E, Rosés M, Neue UD. Comparison of the acidity of residual silanol groups in several liquid chromatography columns. J. Chromatogr. A 986, 33-44 (2003). (Pubitemid 36071532)